Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
HNRNPA2B1 belongs to the A/B subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). Additionally we are shipping HNRNPA2B1 Kits (42) and HNRNPA2B1 Proteins (10) and many more products for this protein.
Showing 10 out of 122 products:
Chicken Monoclonal HNRNPA2B1 Primary Antibody for ICC, IHC (fro) - ABIN108622
Kamma, Horiguchi, Wan, Matsui, Fujiwara, Fujimoto, Yazawa, Dreyfuss: Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. in Experimental cell research 1999
Show all 11 Pubmed References
Chicken Monoclonal HNRNPA2B1 Primary Antibody for ICC, IHC (fro) - ABIN108621
Maeto, Knott, Linero, Ellenberg, Scolaro, Castilla: Differential effect of acute and persistent Junin virus infections on the nucleo-cytoplasmic trafficking and expression of heterogeneous nuclear ribonucleoproteins type A and B. in The Journal of general virology 2011
Show all 11 Pubmed References
Chicken Monoclonal HNRNPA2B1 Primary Antibody for ICC, IF - ABIN267486
Hou, Lersch, Gee, Ponthier, Lo, Wu, Turck, Koury, Krainer, Mayeda, Conboy: Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. in The EMBO journal 2002
Show all 2 Pubmed References
Human Monoclonal HNRNPA2B1 Primary Antibody for IF, ELISA - ABIN561313
McDonald, Aulas, Destroismaisons, Pickles, Beleac, Camu, Rouleau, Vande Velde: TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. in Human molecular genetics 2011
revealed a novel heterozygous missense mutation of hnRNPA2B1 gene (c.929C>T, p. P310L) in the two patients which was then verified in all affected individuals
Cilostazol pretreatment can reduce the excessive expression of inflammatory cytokines and chemokines and hnRNP A2/B1 by the Behcet's disease-related stimulants.
UCP2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreatic cancer cells to glycolysis inhibition.
We demonstrate that the wild-type sequence harbors an hnRNP A1 (show HNRNPA1 Antibodies) and hnRNP A2/B1-binding exonic splicing silencer (ESS) overlapping the 5'splice site (5'ss) that prevents pseudoexon inclusion.we demonstrate that splice switching oligonucleotide (SSO) mediated blocking of the pseudoexon 3'ss and 5'ss effectively restores normal GLA (show NAT8 Antibodies) splicing
Data suggest that galectin-3 (show LGALS3 Antibodies) and heterogeneous ribonucleoprotein particle component hnRNPA2B1 interact as members of the early splicing machinery.
effect of mutations on the aggregation propensity of hnRNPA2
ALS-associated hnRNPA2B1 D290V mutant patient fibroblasts and motor neurons differentiated from iPSCs (iPSC-MNs) demonstra (show IGFALS Antibodies)te abnormal splicing changes, likely d (show DAO Antibodies)ue to increased nuclear-insoluble hnRNPA2B1. Mutant iPSC-MNs display decreased survival in long-term culture and exhibit hnRNPA2B1 localization to cytoplasmic granules as well as exacerbated changes in gene expression and splicing upon cellular stress.
Motor-neuron disease (MND (show CLN8 Antibodies))-linked RNA-binding proteins (RBPs), TDP-43 (show TARDBP Antibodies), FUS (show FUS Antibodies), and hnRNPA2B1, bind to and induce structural alteration of UGGAAexp. These RBPs suppress UGGAAexp-mediated toxicity in Drosophila by functioning as RNA chaperones for proper UGGAAexp folding and regulation of pentapeptide repeat translation.
To examine the relationship between amino acid sequence and aggregation propensity, a diverse set of point mutations in the hnRNPA2B1 prion (show PRNP Antibodies)-like domain.
We concluded that hnRNPA2B1 promotes the tumorigenic potential of breast cancer cells, MCF-7 and MDA-MB-231, through the extracellular-signal-regulated kinase 1/2 (show MAPK3 Antibodies) or signal transducer and activator of transcription 3 (show STAT3 Antibodies) pathway, which may serve as a target for future therapies.
HnRNP A2/B1 loss results in alternative splicing (AS), including skipping of an exon in amyotrophic lateral sclerosis (ALS)-associated D-amino acid oxidase (DAO (show DAO Antibodies)) that reduces D-serine metabolism.
Findings suggest that hnRNP A2/B1 has an important role in regulation of the innate immune system, especially at the level of monocyte/macrophage activation.
hnRNPA2/B1 plays a functional role in SMC differentiation from stem cells in vitro and embryonic branchial arch artery development.
splicing repressors hnRNP A1 and A2, as well as the polypyrimidine-tract-binding protein PTB, contribute to control of pyruvate kinase isoform M1 and M2 expression
overproduction of TNF-alpha leads to aberrant expression of hnRNP-A2 in the rheumatoid joint and subsequently to autoimmune reactions, which may enhance the inflammatory and destructive process.
These results are consistent with a model where hnRNP E1 recruited to A2RE RNA granules by binding to hnRNP A2 inhibits translation of A2RE RNA during granule transport.
Active Fyn (show FYN Antibodies) phosphorylates hnRNP (show HNRNPH2 Antibodies) A2 and stimulates translation of an myelin basic protein (MBP (show MBP Antibodies)) A2RE (A2 response element) -containing reporter construct.
A common mechanism of mitochondrial respiratory stress-induced activation of nuclear target genes that involves hnRNP A2 as a transcription coactivator, is described.
This gene belongs to the A/B subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has two repeats of quasi-RRM domains that bind to RNAs. This gene has been described to generate two alternatively spliced transcript variants which encode different isoforms.
heterogeneous nuclear ribonucleoproteins A2/B1
, hnRNP A2 / hnRNP B1
, nuclear ribonucleoprotein particle A2 protein
, heterogeneous nuclear ribonucleoprotein A2/B1
, Heterogeneous nuclear ribonucleoprotein A2 homolog 1
, heterogenous nuclear ribonucleoprotein A2/B1
, hnRNP A2/B1
, heterogeneous nuclear ribonucleoprotein A2
, heterogeneous nuclear ribonucleoprotein B0a
, heterogeneous nuclear ribonucleoprotein B0b
, heterogeneous nuclear ribonucleoprotein B1